An update on the clinical approach to giant cell arteritis

Keyphrases

• Giant Cell Arteritis 100%
• Clinical Approach 100%
• Clinical Outcomes 33%
• Clinical Efficacy 33%
• Expert Opinion 33%
• Diagnostic Delay 33%
• Patient Outcomes 33%
• Tocilizumab 33%
• Sparing Effect 33%
• Rheumatology 33%
• Medical Experts 33%
• Interleukin-6 Inhibitors 33%
• Cranial Ultrasound 33%
• Global Guidance 33%
• Randomized Controlled Trial Evidence 33%
• Glucocorticoid Sparing 33%
• National Guidance 33%
• High-dose Glucocorticoids 33%

Medicine and Dentistry

• Giant-Cell Arteritis 100%
• Medical Decision Making 100%
• Glucocorticoid 66%
• Receptor Antagonist 33%
• Randomized Controlled Trial 33%
• Decision Making 33%
• Drug Megadose 33%
• Diagnostic Delay 33%
• Rheumatology 33%
• Interleukin 6 Receptor 33%
• Tocilizumab 33%